Several strategies have been devised to obliterate the left atrial appendage (LAA) space, which is the suspected origin of the majority of cardioembolic thrombi in patients with non-valvular atrial fibrillation (NVAF) - related stroke (1). The OMEGA™ LAA occluder is a novel self-expandable, cup-and-disc device made from a continuous, platinum-coated nitinol wire mesh (Figure 1), designed to occlude the LAA. The cup and disc are linked together by a flexible connecting waist. The disc has a polypropylene fabric securely sewn inside it, adding to the occlusive aspect of the device. For stabilization, the cup carries 6 to 10 anchoring hooks. This study reports on the first-in-human experience and procedural safety and efficacy of the OMEGA™ LAA occluder.
2. Cardiac Center and Division of Cardiovascular Disease, Department of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand
3. The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Denmark
4. Cardiac Center and Department of Radiology, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.
Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.
To read the full content of this article, please log in to download the PDF.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com